Evidence map›Paper›PMID 18250154›Full record

ArticleMolecular and cellular biology2008

Identification of ZBP-89 as a novel GATA-1-associated transcription factor involved in megakaryocytic and erythroid development.

Andrew J Woo, Tyler B Moran, Yocheved L Schindler, Seong-Kyu Choe, Nathaniel B Langer, Matthew R Sullivan, Yuko Fujiwara, Barry H Paw, Alan B Cantor

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.Advances in experimental medicine and biology · 2024
    Review
  6. Zfp281 and Zfp148 control CD4Science immunology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The zebrafish: A fintastic model for hematopoietic development and disease.Wiley interdisciplinary reviews. Developmental biology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Development and differentiation of the erythroid lineage in mammals.Developmental and comparative immunology · 2016
    Review
  17. Article
  18. Review
  19. Article
  20. TMEM14C is required for erythroid mitochondrial heme metabolism.The Journal of clinical investigation · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andrew J WooDepartment of Pediatric Oncology, Children's Hospital Boston/Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Tyler B Moran
Yocheved L Schindler
Seong-Kyu Choe
Nathaniel B Langer
Matthew R Sullivan
Yuko Fujiwara
Barry H Paw
Alan B Cantor
Harvard University · USBrigham and Women's Hospital · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
Frascati: mitochondrial transporter and erythropoiesisR01DK070838 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI PAW, BARRY H · 2007 to 2011
$1.8M
Proteomic Study of Megakaryocyte Transcriptional ControlR01HL075705 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI CANTOR, ALAN B. · 2004 to 2007
$1.4M
NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL 075705NHLBI NIH HHS R01 HL075705NIDDK NIH HHS R01 DK070838
6 · The paper itself

Abstract

A complete understanding of the transcriptional regulation of developmental lineages requires that all relevant factors be identified. Here, we have taken a proteomic approach to identify novel proteins associated with GATA-1, a lineage-restricted zinc finger transcription factor required for terminal erythroid and megakaryocytic maturation. We identify the Krüppel-type zinc finger transcription factor ZBP-89 as being a component of multiprotein complexes involving GATA-1 and its essential cofactor Friend of GATA-1 (FOG-1). Using chromatin immunoprecipitation assays, we show that GATA-1 and ZBP-89 cooccupy cis-regulatory elements of certain erythroid and megakaryocyte-specific genes, including an enhancer of the GATA-1 gene itself. Loss-of-function studies in zebrafish and mice demonstrate an in vivo requirement for ZBP-89 in megakaryopoiesis and definitive erythropoiesis but not primitive erythropoiesis, phenocopying aspects of FOG-1- and GATA-1-deficient animals. These findings identify ZBP-89 as being a novel transcription factor involved in erythroid and megakaryocytic development and suggest that it serves a cooperative function with GATA-1 and/or FOG-1 in a developmental stage-specific manner.

Indexed as

Cell DifferentiationAmino Acid SequenceAnimalsAnimals, Genetically ModifiedCell LineDNA-Binding ProteinsEmbryonic Stem CellsEmbryo, NonmammalianErythroid CellsGATA1 Transcription FactorMegakaryocytesMiceMolecular Sequence DataPloidiesProtein BindingRatsDNA-Binding ProteinsGata1 protein, mouseGATA1 Transcription FactorTranscription FactorsZebrafish ProteinsZfp148 protein, mouseZfp148 protein, ratznf148 protein, zebrafish

Identifiers

PMID18250154
PMCPMC2293107
OpenAlexW2171006421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.